The initial Australian experience of Technetium-99m sestamibi scintimammography: A complementary test in the management of breast cancer

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 7, 1997, Pages 433-437

  Sillar, Robert ^a   Howarth, Douglas ^a   Clark, David ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Breast cancer Technetium 99 m sestamibi scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST PROSTHESIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAMMOGRAPHY;

EID: 0030744445     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb02009.x     Document Type: Article

References (30)

1. McCredie M, Hopper JL, Cawson JN. Risk factors and preventive strategies for breast cancer. Med. J. Aust. 1995; 163: 435-40.
2. Giles G, Thursfield V, Staples M. The bottom line trends in cancer mortality. Australia 1950-1991. Cancer Forum 1994; 18: 12-23.
3. American Cancer Society. Cancer Facts and Figures. New York: ACS Inc, 1983.
4. Kricker A, Hoyer AP, McCredie M, Porter LA. Breast cancer in NSW women: A shift in tumour size. Med. J. Aust. 1995; 163: 79-81.
5. Waldemar A, Schmidt J. The triple test: A cost effective tool. Lab. Med. 1994; 25: 714-19.
6. Kapons DB. Positive predictive value of mammography. AJR 1992; 158: 521-6.
7. Khalkali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: A new role of prone scintimammography using technetium-99m sestamibi. Eitr. J. Nucl. Med. 1994; 21: 357-62.
8. Kiat H, Maddahi J, Roy LT et al. Comparison of technetium- 99m methoxyisobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am. Heart J. 1989; 117: 1-11.
9. Chui ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J. Nucl. Med. 1990; 31: 1646-53.
10. Caner B, Kitapci M, Aras T, Erbengi G, Ugur O, Bekdik C. Increased accumulation of hexakis (methoxyisobutylnitrile) technetium (I) in osteosarcoma and its metastatic lymph nodes. J. Nucl. Med. 1991; 32: 1977-8.
11. O'Tuama LA, Packard AB, Trêves ST. SPECT imaging of pédiatrie brain tumor with hexakis (methoxyisobutylnitrile) technetium (I). J. Nucl. Med. 1990; 31: 2040-1.
12. Nakahara H, Noguchi S, Murakami N et al. Technetium-99m sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumours. J. Nucl. Med. 1996; 37: 901-4.
13. Kitapci MT, Tastekin G, Turgut M et al. Preoperative localization of parathyroid carcinoma using Tc-99m MIBI. Clin. Nucl. Med. 1993; 18: 217-19.
14. Hassan IM, Sahwell A, Milroy R et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin. Nucl. Med. 1989; 14: 333-40.
15. Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin. Nucl. Med. 1992; 17: 936-7.
16. Hisada K, Tonami N, Miyamae T et al. Clinical evaluation of tumour imaging with Tl-201 chloride. Radiology 1978; 129: 497-500.
17. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumours: Preliminary results and comparison with Tl-201. Clin. Nucl. Med. 1992; 17: 171-6.
18. Kalkhali I, Mena I, Jouanne E et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J. Am. Coll. Surg. 1994; 178: 491-7.
19. Burak Z, Argon M,.Memis A et al. Evaluation of palpable breast masses with Tc-99m MIBI: A comparative study with mammography and ultrasonography. Nucl. Med. Commun. 1994; 15: 604-12.
20. Kalkhali I, Cutrone JA, Mena IG et al. Scintimammography: The complementary role of technetium-99m sestamibi scintimammography in improvement of the sensitivity and specificity of mammography in detection of carcinoma of the breast. Radiology 1995; 196: 421-6.
21. Khalkhali I, Villanueva-Meyer J, Edell SL et al. Diagnostic accuracy of Tc-99m sestamibi breast imaging in breast cancer detection (Abstract). J. Nucl. Med. 1996; 35: 74.
22. Villanueva-Meyer J, Briscoe LE, Cesani Fet al. Mammoscintigraphy with technetium-99m sestamibi in suspected breast cancer. J. Nucl. Med. 1996; 37: 926-30.
23. Taillefer R, Robidoux A, Turpin S et al. Detection of axillary lymph node involvement with Tc-99m sestamibi imaging in patients with primary breast cancer (Abstract). J. Nucl. Med. 1996; 35: 75.
24. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Klein S. Breast cancer staging using Tc-99m sestamibi scintimammography (SMM) (Abstract), din. Nucl. Med. 1995; 20: 858.
25. Wahl RL, Helvie MA, Chang AE, Anderson I. Detection of breast cancer in women after augmentation mammoplasty using fluorine 18-fluorodeoxygIucose-PET. J. Nucl. Med. 1994; 35: 872-5.
26. Lesser ML, Rosen PP, Kinne D\V. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982; 91: 234-40.
27. Gump FE. Lobular carcinoma in situ: Pathology and treatment. Surg. Clin. North Am. 1990; 70: 873-83.
28. Chaudrey MA, Millis RR, Hoskins EO, Halder M. Bilateral primary breast cancer: A prospective study of disease incidence. Br. J. Surg. 1984; 71: 1501-27.
29. Robbins GF, Berg JW. Bilateral breast cancers. Cancer 1964; 17: 1501-27.
30. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. Br. J. Cancer 1957; 11: 359-77.